FGFR1 and lung adenocarcinoma: It was reported that the FGFR1 amplification could be detected in about 10%–20% of the lung SQCC, with lower frequency in 1%–5% of lung adenocarcinoma [25, 27, 28], which was consistent with the results of our meta-analysis.